2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92562°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
4³âÁ¦ ´ëÁ¹ÀÚ Àý¹ÝÀº Á÷¹« ºÒÀÏÄ¡ °æÇè (2018-08-02)
´«¿îµ¿, ½Ã·Â°ü¸®¿Í ÁýÁß·ÂÇâ»ó¿¡ µµ¿ò (2013-06-11)
³ëÇüµ·, 28ÀÏ ½Å°î ¡®ÇູÇÏ±æ ¹Ù¶ö »ÓÀÌÁÒ¡¯ ¹ßÇ¥ (2018-11-28)
¡®ÃÊ´ç¿Á¼ö¼ö¡¯ ´©Àû ÆÇ¸Å·® 200¸¸°³ µ¹ÆÄ¡¦ (2020-08-15)
ȯÀÚ ÀÌ¼Û ¹× ÀçȰ ±â´ÉÀÇ ¸ð¹ÙÀÏ Áö´ÉÇü ·Îº¿ (2020-10-13)
±èÇØ »ï¹æ½ÃÀå, Á¦1ȸ ¼Òdz¿ä¸®°æ¿¬´ëȸ °³ÃÖ (2018-11-16)
¡®¼¼°èÃÖÃÊ KT 5GÅ׸¶ÆÄÅ©¡¯ 1´Ü°è ¿ÀÇ (2019-05-24)
LGÀüÀÚ, »õ·Î¿î ¡®G Pro Song¡¯ ¿µ»ó °ø°³ (2013-04-24)
The Polypill Reduces Cardiovascular Mortality by 33% in Pati... (2022-08-29)
À¯ÀüÀÚ °Ë»ç ±â¹Ý ÇコÄÉ¾î ¼­ºñ½º Ãâ½Ã (2020-10-01)
¾ÆÅÂÁö¿ª ¿¡³ÊÁö Àüȯ ¾ÆÁ÷ Ãʱ⠴ܰè (2022-04-21)
º£´º, 3000¹ÌÅÍ »ó°ø¿¡¼­ È­·ÁÇÏ°Ô µîÀåÇÏ´Ù (2019-07-10)
ºñÀÚ, Ç÷¹À̵å Àμö (2020-01-15)
ûÃá³²³àµé, ¦ ã¾Æ ¼­Çö¿ª ·Îµ¥¿À°Å¸®¿¡ ¸ðÀδ٠(2013-08-08)
ÀϺ»°æÁ¦, ÁßÀå±âÀû ºÒÈ®½Ç¼º ¿©Àü (2013-03-31)
IoT·Î °ø±ÞüÀÎ °ü¸® Çõ½Å ±â´ë (2019-09-07)
À̱¸½º, µðÁöÅÐ Æ®À© ·Îº¿ Á¦¾î ½Ã½ºÅÛ ¼±º¸¿© (2020-09-19)
¼­ºñ½ºÇ÷£ ÄÚ¸®¾Æ, ºÎ»ê±¹Á¦±¤°íÁ¦ 6°³ ºÎ¹® ¼ö»ó (2019-08-26)
FEELM Granted e-Cigarette Production License (2022-08-17)
½º¿Ï¼Û ¾Ó»óºí ÇÁ·ÎÁ§Æ® 2Áý µà¿À ¸ð½î ¡®»ì·Õ µå ¹ÂÁ÷¡¯ (2018-08-01)
±¹¾Ç°ú ÆËÆä¶óÀÇ Ä÷¡¹ö·¹ÀÌ¼Ç ¡®»ç¶û, ²ÉÇÇ°í ³ë·¡ÇÇ°í¡¯ (2018-05-22)
Á¶¼± ±âÀÚÀç ¾÷ü À§±â, Ãß°æ »ç¾÷ Á¶±â½ÃÇà (2019-08-14)
Àδõ½ºÆ®¸® 4.0 - Æø¹ß À§Ç迵¿ª¿¡ ±¸ÃàÇÏ´Â ¿µ¸®ÇÑ ÀÎÅͳݸÁ (2013-04-11)
Á¦·ÎÆäÀÌ, ÄÚ¸®¾Æ¼¼ÀÏÆä½ºÅ¸ À̺¥Æ® (2020-11-05)
ÀÚ¿¬ÀçÇØ ÀÔÀº Çʸ®ÇÉ ¼Û±Ý ¼ö¼ö·á ¸éÁ¦ (2020-11-05)
       [ÀÌÀü][1]....[3444][3445][3446][3447][3448][3449][3450][3451][3452]...[3703][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..